Regulating forensic genetic genealogy
By Natalie Ram, Erin E. Murphy, and Sonia M. Suter,
Science
| 09. 24. 2021
In May 2021, Maryland enacted the first law in the United States—and in the world—that comprehensively regulates law enforcement’s use of consumer genetic data to investigate crimes (1). Until now, the primary restraint on law enforcement has come from consumer genetics platforms themselves, with some declining to cooperate, some covertly cooperating, and a handful working openly with criminal investigators. Courts have largely taken a hands-off approach, and one of the only efforts at oversight emerged from the US Department of Justice (DOJ), which issued an “interim” policy in November 2019. By contrast, Maryland’s new law—adopted with near-unanimous, bipartisan support—engaged a broad array of stakeholders and was adopted by elected officials after a transparent and open legislative process. Its success provides a roadmap for regulating genetic genealogy in a way that balances privacy and public safety, and its terms include six critical features that others should model moving forward.
Solving Crimes, Provoking Alarm
The technology at issue in the Maryland law came to the public’s attention with the high-profile arrest of Joseph James DeAngelo Jr. as the Golden State...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...